Clinical Pharmacokinetics of the CD19 Receptor‐Directed Tyrosine Kinase Inhibitor B43‐Genistein in Patients with B‐Lineage Lymphoid Malignancies
暂无分享,去创建一个
F. Uckun | A. Levine | F. Goldman | Y. Messinger | D. E. Myers | J. Casper | Chun-Lin Chen | A. Rao | K. O'Neill | C. Hurvitz